glp 1 low energy GLP-1 and balance: an integrated model of short-term and long-term control Low energy on GLP-1s: how

Ozempic & Deep Vein Thrombosis (DVT) / Blood Clot Risks February 20, 2024, Ernie Mundell, GLP-1 Meds May Lower Clot Risk in People With Diabetes, Dec 10, 2024, American Heart Association Scientific Sessions, GLP-1, SGLT2 medications may lower stroke survivors risk of future heart attack, stroke2024, Abstract 4148007 Roua Anamaria Iorga, Nicolae Bacalbasa, Mara Carsote, Ovidiu Gabriel Bratu, Ana Maria Alexandra Stanescu, Simona Bungau, Carmen Pantis, Camelia Cristina Diaconu, Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review) Exp Ther Med 2020 May 5;20(3):23962400.

Lower levels, from perimenopause, can lead to loss of muscle mass and reduced energy expenditure, decreased insulin sensitivity, and fat storage around the belly

Q: What should I eat while on GLP-1 medications

Of those 161 patients, 16 (10%) experienced recurrent acute pancreatitis after GLP-1 receptor agonist therapy (mean duration 10.8 7.2 months): 6 (38%) were caused by the GLP-1 receptor agonist (as clinically determined by the treating medical team), three (18%) were due to hypertriglyceridemia, two (12%) due to alcohol use, one (6%) due to another oral hypoglycemic agent, one (6%) due to ampulla stenosis, and three (19%) were idiopathic

Both studies share same result from their meta-analysis that allulose contributes to less incremental AUC compared to their controls

Neither is published on the site right now